Targeting cancer cells using 3-bromopyruvate for selective cancer treatment

Cancer treatment deserves more research efforts despite intensive conventional treatment modalities for many types of malignancies. Metastasis and resistance to chemotherapy and radiotherapy receive a lot of global research efforts. The current advances in cancer biology may improve targeting the critical metabolic differences that distinguish cancer cells from normal cells. Cancer cells are highly glycolytic for energy production, exhibit the Warburg effect, establish aggressive acidic microenvironment, maintain cancer stem cells, exhibit resistance to chemotherapy, have low antioxidant systems but different ΔΨm (delta psi, mitochondrial transmembrane potential), express P-glycoprotein for multidrug resistance, upregulate glucose transporters and monocarboxylate transporters and are under high steady-state reactive oxygen species conditions. Normal cells differ in all these aspects. Lactate produced through the Warburg effect helps cancer metastasis. Targeting glycolysis reactions for energy production in cancer cells seems promising in decreasing the proliferation and metastasis of cancer cells. 3-bromopyruvate makes use of cancer biology in treating cancer cells, cancer stem cells and preventing metastasis in human cancer as discussed in this review. Updated advances are analyzed here, which include research analysis of background, experience, readings in the field of cancer biology, oncology and biochemistry.ملخص البحث:ملخص البحث: تناقش هذه المراجعة كيفية التعامل مع الخلايا السرطانية للتمكن من العلاج الانتقائي لها ويعتبر الشفاء من مرض السرطان من التحدي الكبير للأطباء، بالرغم من تواجد طرق العلاج التقليدية. كذلك فان نمو سرطاني ثانوي (Metastasis) ومقاومة الورم للعلاج الكيميائي والشعاعي لا زالت موجودة. لذا فان علاج مرض السرطان لابد أن يستفيد من التطورات الحديثة في بيولوجية السرطان وذلك باستهداف الخلايا السرطانية فقط.